Tag: the war on (some) drugs

California Senators Approve Bill To Let Marijuana Growers Sell Directly To Consumers At Farmers Markets

California senators have advanced an Assembly-passed bill that would allow regulators to issue a new license allowing small marijuana growers to sell their products directly to consumers at state-organized farmers markets and other temporary events.

The legislation from Assemblymember Gail Pellerin (D) was unanimously approved in the Senate Appropriations Committee in a 4-0 vote on Thursday. Adults would also be able to consume cannabis on-site at approved events.

The bill cleared the Assembly in late May with nearly unanimous support before moving to the Senate, where it passed through two committees. It now heads to the floor.

If approved, it will still need to go back to the Assembly for concurrence on Senate amendments, including one stipulating that the licensee can only sell and allow on-site consumption at “state temporary events.” The original language was broader, permitting such activity at “specified temporary events.”

The Senate Appropriations Committee also amended the legislation to delay implementation until January 1, 2026.

Under the proposal, the Department of Cannabis Control (DCC) would be authorized to issue “a state temporary event license to a licensee authorizing onsite cannabis sales to, and consumption by, persons 21 years of age or older at certain venues expressly approved by a local jurisdiction, as specified,” the bill text says.

Local jurisdictions would need to consent to allowing the events in order for a license to be granted.

Keep reading

New Florida Bill Would Ban Public Smoking If Voters Approve Marijuana Legalization On The Ballot

Gov. Ron DeSantis (R) has publicly stated that one of the main reasons why Floridians should reject a measure legalizing recreational cannabis for adults in November is that the smell of people smoking the herb will make the state a less enjoyable place to live.

“This state will start to smell like marijuana in our cities and counties,” he said days after the Florida Supreme Court approved putting Amendment 3 on the ballot. “It will reduce the quality of life.”

To combat that concern, Sarasota Republican state Sen. Joe Gruters said Thursday that he’ll introduce legislation next year banning smoking in all public places in Florida.

The former Republican Party of Florida Chairman stunned some of his colleagues two weeks ago when he came out in support of the proposed constitutional amendment, but said that he wants to get ahead of the concerns that DeSantis and others have expressed about side effects.

“People don’t want to go outside and smell it,” Gruters said on a remote conference call with reporters.” They don’t want to see it in public places. And so, to me, let’s follow the Arizona law and let’s go ahead and ban public smoking in all public places. I think this is easy to do, this is well within our authority, and I think that we need to get ahead of this. And that’s the whole purpose of the bill. It’s very simple.”

In the referendum that Arizona voters passed in 2020 legalizing cannabis for recreational use, the specific text of the law says that it “does not allow any person to smoke marijuana in a public place or open space.”

Keep reading

Prescription Drugs Are the Leading Cause of Death

Overtreatment with drugs kills many people, and the death rate is increasing. It is, therefore, strange that we have allowed this long-lasting drug pandemic to continue, and even more so because most of the drug deaths are easily preventable.

In 2013, I estimated that our prescription drugs are the third leading cause of death after heart disease and cancer,1 and in 2015, that psychiatric drugs alone are also the third leading cause of death.2 However, in USA, it is commonly stated that our drugs are “only” the fourth leading cause of death.3,4 This estimate was derived from a 1998 meta-analysis of 39 US studies where monitors recorded all adverse drug reactions that occurred while the patients were in hospital, or which were the reason for hospital admission.5

This methodology clearly underestimates drug deaths. Most people who are killed by their drugs die outside hospitals, and the time people spent in hospitals was only 11 days on average in the meta-analysis.5 Moreover, the meta-analysis only included patients who died from drugs that were properly prescribed, not those who died as a result of errors in drug administration, noncompliance, overdose, or drug abuse, and not deaths where the adverse drug reaction was only possible.5

Many people die because of errors, e.g., simultaneous use of contraindicated drugs, and many possible drug deaths are real. Moreover, most of the included studies are very old, the median publication year being 1973, and drug deaths have increased dramatically in the last 50 years. As an example, 37,309 drug deaths were reported to the FDA in 2006 and 123,927 ten years later, which is 3.3 times as many.6

Keep reading

Nebraska Bill To Levy 30% Tax On Consumable Hemp Products Advances Out Of Committee

A legislative committee in Nebraska has advanced a sweeping tax bill that would, among other changes, impose a 30 percent sales tax on “consumable hemp” and CBD products. The proposal, broadly aimed at providing property tax relief, will now be considered by the full legislature.

On Monday, lawmakers on the Revenue Committee passed the bill, LB 34, on a 6–1 vote. The tax package combines various proposals that have been introduced during the state’s special legislative session, called by Gov. Jim Pillen (R) last month to deal with the property tax issue.

As approved by the committee, the bill would set a 30 percent sales tax on “consumable hemp products,” defined as finished products that contain hemp and that contain no more than 0.3 percent THC. Hemp products made from stalks or seed—that is, for fiber or food use—would not be included in the definition, nor would pharmaceuticals approved by the federal Food and Drug Administration (FDA).

Revenue Committee chair Sen. Lou Ann Linehan (R), who has played a central role in the tax discussion, first introduced the 30 percent hemp tax two weeks ago, in an earlier bill she sponsored. A separate proposal she introduced during the regular legislative session would have taxed consumable hemp and CBD at 100 percent, a rate that was later reduced to 25 percent before the underlying bill fizzled out.

“The 100% tax was unworkable for CBD companies in our state. They were concerned it would drive them out of business,” Sen. Anna Wishart (D), who’s backed past efforts to end marijuana prohibition in the state, told Marijuana Moment in an email at the time. “In talking with representatives from a group of CBD companies in the state, I worked with them and other senators to negotiate the tax down to 25%.”

The rate is now at 30 percent in the bill moving to the floor.

Keep reading

Marijuana Users Have Better Outcomes Following Heart Attacks, New Study Finds, Pointing To ‘Cannabis Paradox’

Findings of a newly published study show what authors describe as a “cannabis paradox”: Despite concerns that marijuana use may be associated with some heart problems, adults admitted to the hospital after suffering heart attacks actually seemed to fare better if they were cannabis consumers.

“The findings of our study reveal a paradox,” researchers wrote. “Among patients aged 18–80 years admitted to hospital with [acute myocardial infarction] between 2001 and 2020 in the United States, cannabis use was associated with lower risks of complications, such as, cardiogenic shock, acute ischaemic stroke, cardiac arrest, and [percutaneous coronary intervention] use, as well as lower in-hospital mortality despite correcting for several confounding factors.”

“This highlights how cannabis remains a poorly understood substance,” they added, “despite a relentless rise in consumption and social acceptance.”

The report, published in the journal Archives of Medical Science – Atherosclerotic Diseases, examined data from the National Nationwide Inpatient Sample, a database of hospital discharge records across the United States that authors said “represents more than 97% of the US population.”

Keep reading

Utility company’s proposal to rat out hidden marijuana operations to police raises privacy concerns

Operators of illegal marijuana grow enterprises hidden inside rural homes in Maine don’t have to worry much about prying neighbors. But their staggering electric bills may give rise to a new snitch.

An electric utility made an unusual proposal to help law enforcement target these illicit operations, which are being investigated for ties to transnational crime. Critics, however, worry the move would violate customers’ privacy.

More than a dozen states that legalized marijuana have seen a spike in illegal marijuana grow operations that utilize massive amounts of electricity. And Maine’s Versant Power has been receiving subpoenas — sometimes for 50 locations at a time — from law enforcement, said Arrian Myrick-Stockdell, corporate counsel. It’d be far more efficient, he suggested to utility regulators, to flip the script and allow electric utilities to report their suspicions to law enforcement.

“Versant has a very high success rate in being able to identify these locations, but we have no ability to communicate with law enforcement proactively,” Myrick-Stockdell told commissioners.

Keep reading

80 Bipartisan Lawmakers Push FDA To Seriously Consider Approving MDMA-Assisted Therapy

A bipartisan and bicameral coalition of congressional lawmakers is expressing urgency to the federal government as it looks into the possibility of authorizing MDMA-assisted therapy, particularly as it concerns veterans with severe mental health conditions.

A total of 80 members of Congress—including 19 senators and 61 representatives from the House—sent separate letters to the Biden administration and the head of the Food and Drug Administration (FDA) this past week, urging serious consideration of approving the psychedelic as a treatment option for post-traumatic stress disorder (PTSD).

MDMA is “one of the most promising and available options to provide reprieve for veterans’ endless PTSD cycle,” the Senate letter says, noting that FDA has already designated it as a breakthrough therapy.

This comes about a month after an FDA advisory panel rejected an application to authorize MDMA-assisted therapy. Bipartisan lawmakers separately staged an event at the U.S. Capitol calling for the MDMA approval and also launched an art installation memorializing military veterans who die by suicide.

“FDA should remain firmly anchored in scientific evidence and data when evaluating new treatments,” the new letter, led by Sens. Michael Bennet (D-CO), Thom Tillis (R-NC), Kyrsten Sinema (I-AZ) and Rand Paul (R-KY), says. “The potential for groundbreaking advancements in PTSD treatment is within reach, and we owe it to our veterans and other affected populations to review these potentially transformative therapies based on robust clinical and scientific evidence.”

Keep reading

New Hampshire Governor Signs Bill Allowing Medical Marijuana For Any Condition A Doctor Thinks It Can Help

New Hampshire Gov. Chris Sununu (R) has signed into a law a major medical marijuana expansion bill that will allow doctors to recommend cannabis for any debilitating condition they believe it would improve. Previously, patients needed to be diagnosed with certain specific conditions to qualify for legal marijuana access.

“This is BIG,” Rep. Wendy Thomas (D), sponsor of the newly signed HB 1278, said in an email to Marijuana Moment. “It opens up the therapeutic program to ANY person who has a debilitating or terminal illness.”

Thomas, a cancer survivor and medical marijuana patient herself, told colleagues at a committee hearing earlier this year that cannabis has helped her manage chronic pain, insomnia, eating issues, gastrointestinal issues, PTSD and anxiety. “I found relief from all of these symptoms,” she said, “some of which are not covered in the program.”

The new law adds to the state’s qualifying conditions for medical marijuana “any debilitating or terminal medical condition or symptom for which the potential benefits of using therapeutic cannabis would, in the provider’s clinical opinion, likely outweigh the potential health risks for the patient.”

The provision does not replace New Hampshire’s enumerated list of qualifying conditions, which Thomas has previously described as a useful way for clinicians who are less familiar with cannabis to navigate the system. “The point of this is that they would be allowed to…refer a patient to the program for any condition that they think would fit and benefit the patient,” she told Marijuana Moment earlier this year.

“This bill sets up two paths for health providers,” Thomas said at the time. “For those who are not familiar with cannabis, they can use the legislated symptom and conditions list. For those providers who are cannabis literate, they will be able to recommend the program for a health condition that they think cannabis may be able to help, but that might not be on the list.”

Other examples of symptoms that could be effectively managed with marijuana that are not specifically listed as qualifying conditions, Thomas said, include severe menstrual cramps, symptoms of long COVID and pre-dentist anxiety and post-surgical pain control.

Keep reading

USDA Adds Another Hemp Industry Representative To Trade Committee To Promote The Crop Globally

The U.S. Department of Agriculture (USDA) and the Office of the U.S. Trade Representative (USTR) have added another hemp industry executive to a federal trade advisory committee to help bolster efforts to promote U.S.-grown cannabis around the world.

Agriculture Secretary Tom Vilsack and USTR Representative Katherine Tai announced on Thursday that they have appointed Dylan Summers, vice president of government affairs for the CBD company Lazarus Naturals, to their Agricultural Technical Advisory Committee (ATAC) for Trade in Tobacco, Cotton, Peanuts and Hemp.

Summers is one of four hemp industry stakeholders on the 14-member ATAC, alongside National Industrial Hemp Council (NIHC) President Patrick Atagi, NIHC board member Patricia Sheikh and the Oregon Hemp Commission’s Eric Pike, who also founded the CBD company Root Origins.

The ATAC focused on tobacco, cotton, peanuts and hemp is one of six advisory committees under USDA and USTRE that offer the government technical advice about specific agricultural commodities and products.

A former marketing executive at NIHC, Kevin Latner, was appointed to a separate ATAC focused on processed foods in 2020. But he’s since left NIHC and is now affiliated with a group that deals with leather materials, while still serving on the committee.

As the latest member, Summers will serve as a hemp representative on the ATAC until at least 2028.

“The advisory committee system was created by Congress to ensure that U.S. agricultural stakeholders have input and insight into U.S. trade policy and negotiating objectives,” USDA said in an advisory. “Applications for committee membership are encouraged at any time and will be considered for future appointments.”

In recognition of hemp’s growing role in the agriculture sector, USDA and USTR formally renamed the ATAC to include last year to include the name of the crop. Previously, the first hemp appointees served on what was then called the ATAC for Trade in Tobacco, Cotton and Peanuts.

Keep reading

Former Secret Service Chief Wanted To Destroy Cocaine Evidence

Former Secret Service Director Kimberly Cheatle and others in top agency leadership positions wanted to destroy the cocaine discovered in the White House last summer, but the Secret Service Forensics Services Division and the Uniformed Division stood firm and rejected the push to dispose of the evidence, according to three sources in the Secret Service community.

Multiple heated confrontations and disagreements over how best to handle the cocaine ensued after a Secret Services Uniformed Division officer found the bag on July 2, 2023, a quiet Sunday while President Biden and his family were at Camp David in Maryland, the sources said.

At least one Uniformed Division officer was initially assigned to investigate the cocaine incident. But after he told his supervisors, including Cheatle and Acting Secret Service Director Ron Rowe, who was deputy director at the time, that he wanted to follow a certain crime-scene investigative protocol, he was taken off the case, according to a source within the Secret Service community familiar with the circumstances of his removal.

Secret Service spokesman Anthony Guglielmi did not immediately return RCP’s request for comment.

The discovery of the bag of cocaine posed an unusual problem for Cheatle, who resigned in the face of bipartisan pressure after the July 13 assassination attempt against Donald Trump.

Hunter Biden had a well-documented addiction to cocaine, crack cocaine, and other substances for many years but repeatedly claimed to be sober since 2021, an assertion that has prompted President Biden to often proclaim how “proud” he is of his son. While neither Joe nor Hunter Biden were at the executive mansion when the cocaine was found, it was discovered after a period when Hunter had been staying there.

Cheatle became close to the Biden family while serving on Vice President Joe Biden’s protective detail – so close that Biden tapped Cheatle for the director job in 2022, in part because of her close relationship to first lady Jill Biden.

Keep reading